GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » 5-Year Dividend Growth Rate

Lanzhou Foci Pharmaceutical Co (SZSE:002644) 5-Year Dividend Growth Rate : 3.30% (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co 5-Year Dividend Growth Rate?

Lanzhou Foci Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2025 was ¥0.00.

During the past 12 months, Lanzhou Foci Pharmaceutical Co's average Dividends Per Share Growth Rate was -40.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -37.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 23.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Lanzhou Foci Pharmaceutical Co was 109.80% per year. The lowest was -37.00% per year. And the median was 13.75% per year.

Lanzhou Foci Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Lanzhou Foci Pharmaceutical Co's Dividend Yield % is 0.38%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Lanzhou Foci Pharmaceutical Co's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Lanzhou Foci Pharmaceutical Co's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lanzhou Foci Pharmaceutical Co's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lanzhou Foci Pharmaceutical Co's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Lanzhou Foci Pharmaceutical Co's 5-Year Dividend Growth Rate falls into.


;
;

Lanzhou Foci Pharmaceutical Co 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Lanzhou Foci Pharmaceutical Co  (SZSE:002644) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Lanzhou Foci Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2025 )/ EPS without NRI (Q: Mar. 2025 )
=0/ 0.051
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Lanzhou Foci Pharmaceutical Co was 1.62. The lowest was 0.08. And the median was 0.12.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Lanzhou Foci Pharmaceutical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.0300002024-06-252024-06-242024-06-25Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Lanzhou Foci Pharmaceutical Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.03/7.91
=0.38 %

Current Share Price is ¥7.91.
Lanzhou Foci Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.03.

During the past 13 years, the highest Dividend Yield of Lanzhou Foci Pharmaceutical Co was 1.71%. The lowest was 0.02%. And the median was 0.16%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lanzhou Foci Pharmaceutical Co 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Lanzhou Foci Pharmaceutical Co's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Lanzhou Foci Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046
Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australia, Russia, and Ukraine, among others.
Executives
Sun Yu Directors, executives
Su Wen Bo Supervisors
An Wen Ting Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines